302440 — SK Bioscience Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩3tn
- KR₩3tn
- KR₩651bn
Annual cashflow statement for SK Bioscience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 355,139 | 122,452 | 22,318 | -50,117 | -56,173 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 130,619 | 36,221 | 7,969 | -166,631 | -56,137 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 32,060 | -310,868 | -35,705 | 39,503 | 123,802 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 536,594 | -124,958 | 29,346 | -128,020 | 102,507 |
| Capital Expenditures | -44,470 | -76,489 | -50,295 | -172,225 | -260,382 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1,377,471 | 349,136 | 5,017 | 225,789 | -101,378 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,421,940 | 272,647 | -45,279 | 53,564 | -361,760 |
| Financing Cash Flow Items | -628 | — | 5,484 | -4,467 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 958,380 | -19,867 | -89,583 | 252,479 | 41,600 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 73,056 | 127,259 | -98,262 | 185,676 | -207,149 |